This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08745/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08745/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08745/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08745
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08745 n12:DB08745
dcterms:title
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE
adms:identifier
n7:XMJ n8:393729 n11:DB08745
n3:IUPAC-Name
n4:271B4FC5-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FCB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FCA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FC7-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FC8-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FC9-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FC3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FC1-363D-11E5-9242-09173F13E4C5 n4:271B4FC4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FC2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4FD1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4FD2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FCC-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FCD-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FCF-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FCE-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FD0-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4FD7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4FD9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4FDA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4FD6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4FD5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4FD8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FC6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4FD3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4FD4-363D-11E5-9242-09173F13E4C5